Evidence map›Paper›PMID 11134068›Full record

ArticleThe Journal of cell biology2000

p53 binding protein 1 (53BP1) is an early participant in the cellular response to DNA double-strand breaks.

L B Schultz, N H Chehab, A Malikzay, T D Halazonetis

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 465 papers.

0numbers the graph read from it
0cells of the map it votes in
465citing papers in PubMed
7.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

465 citing papers in PubMed, 904 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

405 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

L B SchultzDepartment of Molecular Genetics, The Wistar Institute, Philadelphia, Pennsylvania 19104, USA.
N H Chehab
A Malikzay
T D Halazonetis
The Wistar Institute · USUniversity of Pennsylvania · US

Funding

P53 PROTEIN/PROTEIN INTERACTIONSR01CA076367 · NCI · WISTAR INSTITUTE · PI HALAZONETIS, THANOS D · 1998 to 2005
$1.7M
NCI NIH HHS CA76367NCI NIH HHS R01 CA076367
6 · The paper itself

Abstract

p53 binding protein 1 (53BP1), a protein proposed to function as a transcriptional coactivator of the p53 tumor suppressor, has BRCT domains with high homology to the Saccharomyces cerevisiae Rad9p DNA damage checkpoint protein. To examine whether 53BP1 has a role in the cellular response to DNA damage, we probed its intracellular localization by immunofluorescence. In untreated primary cells and U2OS osteosarcoma cells, 53BP1 exhibited diffuse nuclear staining; whereas, within 5-15 min after exposure to ionizing radiation (IR), 53BP1 localized at discreet nuclear foci. We propose that these foci represent sites of processing of DNA double-strand breaks (DSBs), because they were induced by IR and chemicals that cause DSBs, but not by ultraviolet light; their peak number approximated the number of DSBs induced by IR and decreased over time with kinetics that parallel the rate of DNA repair; and they colocalized with IR-induced Mre11/NBS and gamma-H2AX foci, which have been previously shown to localize at sites of DSBs. Formation of 53BP1 foci after irradiation was not dependent on ataxia-telangiectasia mutated (ATM), Nijmegen breakage syndrome (NBS1), or wild-type p53. Thus, the fast kinetics of 53BP1 focus formation after irradiation and the lack of dependency on ATM and NBS1 suggest that 53BP1 functions early in the cellular response to DNA DSBs.

Indexed as

Intracellular Signaling Peptides and ProteinsPhosphoproteinsActive Transport, Cell NucleusAmino Acid SequenceAndrostadienesAntibodies, MonoclonalAntibody SpecificityAtaxia Telangiectasia Mutated ProteinsCaffeineCarrier ProteinsCell Cycle ProteinsCells, CulturedDNADNA-Activated Protein KinaseDNA-Binding ProteinsDNA DamageAndrostadienesAntibodies, MonoclonalAtaxia Telangiectasia Mutated ProteinsATM protein, humanCaffeineCarrier ProteinsCell Cycle ProteinsDNADNA-Activated Protein KinaseDNA-Binding ProteinsIntracellular Signaling Peptides and ProteinsMRE11 Homologue ProteinMRE11 protein, humanNuclear ProteinsPhosphoproteinsPRKDC protein, humanProtein Serine-Threonine KinasesTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53Tumor Suppressor ProteinsWortmannin

Identifiers

PMID11134068
PMCPMC2150674
OpenAlexW1978331091

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.